Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody

This publication has 11 references indexed in Scilit:

• Chimeric and humanized antibodies with specificity for the CD33 antigen.
  The Journal of Immunology, 1992
• A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
  Journal of Clinical Oncology, 1991
• NMR-derived model for a peptide-antibody complex
  Biochemistry, 1990
• Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering
  Protein Engineering, Design and Selection, 1990
• Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
  The Journal of Immunology, 1989
• Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen.
  The Journal of Experimental Medicine, 1988
• The L4F3 antigen is expressed by unipotent and multipotent colony- forming cells but not by their precursors
  Blood, 1986
• A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells
  Leukemia Research, 1984
• Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-.ANG. resolution
  Biochemistry, 1981
• Carbohydrate content of fragments and polypeptide chains of human .gamma.G-myeloma proteins of different heavy-chain subclasses
  Biochemistry, 1968